Synthesis and clinical application of new drugs approved by FDA in 2022
Abstract The pharmaceutical industry had a glorious year in 2022, with a total of 37 new drugs including 20 new chemical entities (NCEs) and 17 new biological entities (NBEs) approved by the Food and Drug Administration (FDA). These drugs are mainly concentrated in oncology, central nervous system,...
| 出版年: | Molecular Biomedicine |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Springer
2023-09-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s43556-023-00138-y |
